| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.046 | 9.904 | 8.454 | 13.890 | 13.773 | 12.731 | 10.970 | 12.061 | 12.069 | 11.927 |
| Total Income - EUR | 10.046 | 9.904 | 8.454 | 13.890 | 13.773 | 12.731 | 10.970 | 12.061 | 20.155 | 11.947 |
| Total Expenses - EUR | 14.282 | 16.080 | 17.183 | 21.511 | 22.114 | 17.457 | 15.097 | 14.237 | 13.208 | 16.928 |
| Gross Profit/Loss - EUR | -4.236 | -6.176 | -8.729 | -7.622 | -8.341 | -4.725 | -4.127 | -2.176 | 6.947 | -4.981 |
| Net Profit/Loss - EUR | -4.537 | -6.283 | -8.814 | -7.760 | -8.478 | -4.854 | -4.237 | -2.289 | 6.746 | -5.100 |
| Employees | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biorex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 12.431 | 11.202 | 11.549 | 7.912 | 5.493 | 1.973 | 2.316 | 1.901 | 1.399 | 2.293 |
| Inventories | 12.424 | 10.909 | 11.325 | 7.344 | 5.017 | 1.895 | 1.511 | 1.532 | -88 | 896 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 210 | 211 | 210 | 302 |
| Cash | 6 | 293 | 224 | 568 | 476 | 79 | 595 | 158 | 1.276 | 1.095 |
| Shareholders Funds | -44.928 | -50.752 | -58.707 | -65.390 | -72.602 | -76.079 | -78.629 | -81.162 | -74.169 | -78.855 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 57.358 | 61.954 | 70.256 | 73.302 | 78.095 | 78.053 | 80.945 | 83.063 | 75.568 | 81.148 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Biorex S.r.l.